Myometrial smooth muscle contractility is regulated predominantly through the reversible phosphorylation of MYLs (myosin light chains), catalysed by MYLK (MYL kinase) -independent inhibition of MYLP in smooth muscle, leading to generation of increased MYL phosphorylation and force for a given [Ca 2 + ] i , a phenomenon known as 'Ca 2 + -sensitization'. ROCK (Rho-associated kinase)-mediated phosphorylation and inhibition of MYLP has been proposed as a mechanism for Ca 2 + -sensitization in smooth muscle. However, it is unclear to date whether the mechanisms that sensitize the contractile machinery to Ca 2 + are important in the myometrium, as they appear to be in vascular and respiratory smooth muscle. In the present paper, we discuss the signalling pathways regulating MYLP activity and the involvement of ROCK in myometrial contractility, and present recent data from our laboratory which support a role for Ca 2 + -sensitization in human myometrium.
Introduction
The uterus is a smooth muscle organ which increases in size during pregnancy, but remains in a state of quiescence until parturition. Subsequently, it is capable of generating strong, synchronized, phasic contractions at the onset of labour; but the physiological and biochemical triggers that guide this transition are still poorly defined. Complex signalling mechanisms exist to couple receptor occupancy of uterotonic agonists at the plasma membrane to changes in myofilament activation in the cytoplasm. Alterations in the timing of labour are the leading cause of neonatal mortality and morbidity. Thus there is an urgent need to investigate the mechanism of spontaneous pre-term labour, which may or may not result from the same endocrine and intracellular pathways as the physiological onset of labour at term. Greater understanding of the pathways regulating myometrial contractility is critical in advancing our knowledge of parturition, and it may provide much needed information to make a clinical impact on the prediction and management of preterm birth. It is important to note that much of the knowledge regarding regulation of smooth muscle contractility discussed below originates from studies using vascular tissue which usually produces sustained tonic contractions. Conversely, the myometrium generates strong, Key words: calcium-sensitization, myometrium, myosin phosphatase, oxytocin, Rho-associated kinase (ROCK), uterine contractility. Abbreviations used: AUC, area under the curve; [Ca 2 + ]i, intracellular calcium concentration; CPI-17, 17 kDa PKC-activated phosphatase inhibitor; GPCR, G-protein-coupled receptor; ILK, integrinlinked kinase; MYL, myosin light chain; MYLK, MYL kinase; MYLP, MYL phosphatase; MYPT1, myosin phosphatase target subunit 1; OXT, oxytocin; PKC, protein kinase C; PKN, protein kinase N; pMYL, phosphorylated MYL; PP1c, catalytic protein phosphatase 1c; ROCK, Rho-associated kinase; siRNA, small interfering RNA; ZIPK, zipper-interacting protein kinase. 1 To whom correspondence should be addressed (email A.LopezBernal@bristol.ac.uk). synchronized, phasic contractions followed by periods of relaxation; these are critical for successful delivery of the baby and re-establishment of blood flow to the placenta during labour. Hence it is likely that uterine-specific signalling mechanisms exist in this remarkable smooth muscle organ.
Pathways regulating contraction in smooth muscle
The primary regulator of smooth muscle contractility is phosphorylation of MYLs (myosin light chains), resulting in increases in myosin ATPase activity and consequently actin-myosin cross-bridge cycling rates. Phosphorylation of MYL (pMYL) is catalysed by MYLK (MYL kinase), an enzyme that responds rapidly to increases in [Ca 2 + ] i (intracellular Ca 2 + concentration) through binding Ca 2 + -calmodulin [1] . Myometrial smooth muscle is myogenic; it can generate contractions spontaneously, without the need for external stimulation. Contraction of myometrial cells is initiated by action potentials that depolarize the cell membrane, allowing the rapid entry of Ca 2 + through voltage-operated channels [2] . Uterotonic agonists such as OXT (oxytocin) can mediate their contractile effects through binding to GPCRs (G-protein-coupled receptors) and activating G q /phospholipase C signalling, also resulting in elevated [Ca 2 + ] i. A large portion of the uterotonic effect of OXT is due to its ability to increase Ca 2 + entry into cells, with a small contribution of Ca 2 + release from the sarcoplasmic reticulum [3] . Dephosphorylation of MYL is catalysed by MYLP (MYL phosphatase), an enzyme that can be regulated by several mechanisms in a Ca 2 + -independent manner. [5] , whereas GPCR agonists contribute to Ca 2 + -sensitization by mechanisms involving G-proteins [6] . It is unclear to date whether mechanisms that sensitize the contractile machinery to Ca 2 + are important in the myometrium, as they appear to be in vascular and respiratory smooth muscle [4] . Alternatively, in the uterus under physiological conditions, control of MYL phosphorylation and force may lie predominantly with MYLK regulation by Ca 2 + .
Involvement of Rho-ROCK (Rho-associated kinase) signalling in myometrial contractility
Agonists binding to G q -and G 12/13 -coupled receptors, such as OXT, are capable of causing activation of Rho family members through Rho-GEFs (Rho guanine-nucleotideexchange factors), or indirectly through PKC (protein kinase C)-mediated activation of Rho-regulatory proteins [7, 8] . When GTP-bound, RhoA is capable of binding to and activating downstream effector molecules such as ROCK. There is direct evidence for RhoA and ROCK2 translocation to the plasma membrane after carbachol stimulation of isolated rat myometrial cells [9] . Evidence from our laboratory supporting the involvement of Rho-ROCK signalling during labour is provided by the finding that RhoA-GTP is increased with pregnancy, and this increase is augmented with spontaneous pre-term labour [10] . RND proteins are members of the Rho family which lack intrinsic GTPase activity and inhibit the RhoA-ROCK pathway either by binding to ROCK and preventing it from phosphorylating downstream targets [11] or by increasing Rho-GTPase activity via p190 Rho-GAP (Rho GTPaseactivating protein) [12] . We have demonstrated a pregnancyrelated up-regulation of RND2 and RND3 in human myometrium [13] . The up-regulation of myometrial RND protein expression is likely to be linked to inhibition of RhoA-ROCK signalling, and may increase MYLP activity that enhances uterine relaxation during pregnancy (see below). We and others have found no change in ROCK1 expression with pregnancy or labour, whereas ROCK2 levels are decreased in pregnant compared with non-pregnant myometrial tissue [10, 14] . Pharmacological inhibition of ROCK using Y27632 can reduce spontaneous and OXTinduced contractility of human myometrium in vitro [15] [16] [17] . Analysis of [Ca 2 + ] i -tension relationships also revealed that Y27632 was capable of decreasing the Ca 2 + -sensitization evoked by OXT [17] . This effect may be caused by the ROCK-dependent phosphorylation of MYLP described below, but there is currently no direct evidence for this.
Other mechanistic explanations include ROCK-dependent phosphorylation of the myosin phosphatase inhibitor CPI-17 (17 kDa PKC-activated phosphatase inhibitor) [18] , or direct phosphorylation of MYL by ROCK [19, 20] .
Glycyl-H-1152-dihydrochloride (H-1152) is a cellpermeant reversible ATP-competitive inhibitor of ROCK1/2. This compound has greater potency than Y27632 (K i = 11.8 nM compared with 140 nM) and shows over 100-fold selectivity for ROCK over other protein kinases such as CaMKII (Ca 2 + /calmodulin-dependent kinase II), PKA (protein kinase A) or PKC [21] . We have found that H-1152 is capable of decreasing OXT-induced contractility of pregnant human myometrial tissue in vitro. After 30 min of incubation with 1 μM H-1152, contractility determined by the integrated AUC (area under the curve) was decreased by approximately 50% (Figure 1 ). Inhibiting ROCK also significantly reduced the baseline tone of the contracting muscle strips as determined by the inter-contractile minimum. There has been controversy between some groups reporting an effect of Y27632 on phasic myometrial contractions [16, 17] and others showing a very minor effect of Y27632 on OXT-induced contractility [15] . It has been suggested that inhibition of ROCK may have a significant effect on force only when the myometrium is contracting tonically after treatment with both KCl and OXT; under non-physiological conditions [15] . Our results, however, indicate a clear effect of H-1152 on decreasing amplitude and duration of phasic contractions in vitro, and suggest that Rho-ROCK signalling may play a defined role during phasic contractility of human myometrium during labour. [22] . Other studies, however, have failed to demonstrate any marked Ca 2 + -sensitizing effect of OXT, vasopressin or phenylephrine in pregnant human myometrium [23] .
Experimental demonstration of agonist-induced

Mechanisms regulating Ca 2 + -sensitivity of smooth muscle
Most of the documented mechanisms of Ca 2 + -sensitization involve inhibition of MYLP activity and are discussed in Results are means + S.E.M., and statistical analysis was performed using a paired Student's t test, *P < 0.001, n = 6. the present paper; however, modulation of MYLK activity by Ca 2 + -independent phosphorylation mechanisms may also play a role [24] ; other kinases may be capable of phosphorylating MYL directly [25, 26] ; and contractionassociated proteins downstream of MYL phosphorylation, such as caldesmon and calponin, can also be regulated by phosphorylation [27] . The MYLP holoenzyme is composed of three subunits: a 38 kDa catalytic protein phosphatase subunit (PP1c); a large 110-130 kDa regulatory subunit [MYPT1 (myosin phosphatase target subunit 1), also known as PPP1R12A (protein phosphatase 1, regulatory inhibitor subunit 12A) or MBP (myosin-binding protein)]; and a small 20 kDa subunit of unknown function (M20). PP1c interacts with the N-terminus of MYPT1 and M20 with the C-terminus, thereby creating a heterotrimeric holoenzyme. The C-terminus of MYPT1 contains a region that is capable of binding Rho-GTP in addition to the myosin-binding domain, making it an important region for docking of MYLP with its activators and substrates.
CPI-17-dependent mechanisms
CPI-17 was purified from pig aorta [28, 29] and is capable of inhibiting activity of MYLP and hence potentiating pMYL levels when phosphorylated itself at Thr 38 [28] . PP1c, the catalytic subunit of MYLP, is unable to hydrolyse phosphoThr 38 , hence causing a stable inhibitory complex to form between PP1c and CPI-17 [30] . Agonist-mediated Thr 38 phosphorylation has been shown to be dependent on PKC, ROCK or ILK (integrin-linked kinase) activities in vascular smooth muscle [18, 31, 32] , whereas CPI-17 is also an in vitro substrate for PKN (protein kinase N) [33] , ZIPK (zipperinteracting protein kinase) [34] and PAK (p21-activated kinase) [35] . Phosphorylation of CPI-17 is reversed upon elevation of cAMP/cGMP during relaxation of arteriole smooth muscle [36] , either by attenuation of PKC and ROCK signalling or through activation of CPI-17 phosphatases. The regulation of CPI-17 and its role in the myometrium are less well defined than in vascular smooth muscle. Previous work from our laboratory has indicated a gestation-related increase in pCPI-17 (Thr 38 ), and this was associated with increases in PKN, a kinase capable of phosphorylating CPI-17 at Thr 38 [10] . Others have demonstrated up-regulation of CPI-17-encoding mRNA and protein expression during pregnancy, and suggest that these changes may explain the increased ability of PKC to mediate contraction of human myometrium during gestation [37] .
CPI-17-independent mechanisms
The catalytic activity of PP1c towards pMYL is greatly reduced when isolated from MYPT1 and M20. Therefore disruption of this interaction by arachidonic acid [38] or PKC-mediated phosphorylation of the N-terminus of MYPT1 [39] inhibits MYLP activity and sensitizes smooth muscle to Ca 2 + . Phosphorylation of the C-terminus of MYPT1 at either Thr 696 or Thr 853 has been proposed to block MYLP activity by a mechanism of autoinhibition [40] , thereby potentiating pMYL production. Enzymes capable of phosphorylating MYPT1 in vitro include ROCK [41] , ZIPK [42] and ILK [43] . ROCK-dependent phosphorylation of one or both of these sites has been demonstrated in smooth muscle cells [44] [45] [46] [47] and rat uterine strips [48] , and phospho-MYPT1 (Thr 853 ) can be increased during Ca 2 + -sensitization of permeabilized vascular smooth muscle induced by phenylephrine or GTP[S] (guanosine 5-[γ -thio]triphosphate) [47] . However, evidence for phosphorylation of MYPT1 at these sites in human myometrial tissue is lacking, and inhibition of MYLP activity as a method of Ca 2 + -sensitization in this tissue remains speculative. To investigate whether MYPT1 is a substrate for ROCK in the myometrium, we have carried out studies in our laboratory using cultured primary human myometrial cells. Inhibition of ROCK with H-1152, or siRNA (small interfering RNA)-mediated knockdown of ROCK1/2, both resulted in significant and potent decreases in phosphorylation of MYPT1 (Thr 853 ), with less marked decreases in pMYPT1 (Thr 696 ) (Figure 2 ). These decreases in pMYPT1 (Thr 853 ) were closely correlated with decreases in pMYL (Thr 18 /Ser 19 ), suggesting that inhibition of ROCK-mediated phosphorylation of MYPT at Thr 853 may be responsible for causing activation of MYLP and hence dephosphorylation of MYL. These data support previous findings in vascular smooth muscle indicating a preference of ROCK for Thr 853 over Thr 696 [45] , and further work is required to elucidate the identity of other myometrial Thr 696 kinases. To investigate further the physiological relevance of MYPT1 phosphorylation, we have extended the studies to fresh myometrial tissue. In order to 'simultaneously' measure myometrial contractility and phosphorylation, we have snapfrozen tissue either between or during spontaneous or agonist-induced phasic contractions. This method reveals increases in phosphorylation of MYL and MYPT1 (Thr 853 ) in tissue frozen at the peak of a contraction when compared with tissue frozen between phasic contractions (Figure 3) . The effects of H-1152 in this system indicate that these phosphorylation events are in part dependent on ROCK activity.
Future perspectives
The combination of data from fresh tissue and cultured cells strongly indicates that Thr 853 is the preferred site for ROCK-mediated phosphorylation of MYPT1 in the myometrium, and that phosphorylation-mediated autoinhibition of MYLP may be responsible for the associated increases in pMYL. However, more work is needed to prove this mechanism. Direct assays of MYLP activity would help to link ROCK-dependent phosphorylation events to tangible decreases in MYLP activity. Other plausible explanations for the effect of H-1152 on myometrial contractility include ROCKdependent phosphorylation of CPI-17, which has been demonstrated in other types of smooth muscle after agonist stimulation [18] . Measuring the levels of phosphorylated CPI-17 in contracting and non-contracting myometrium would help to elucidate its role. An alternative possibility is that ROCK, or a kinase downstream of ROCK, is capable of phosphorylating MYL directly. In vitro phosphorylation of MYL by ROCK, primarily at Ser 19 , has been demonstrated by others [19, 20] , and ROCK is capable of causing contraction of isolated stress fibres from human fibroblasts [49] . The ability of MYLK inhibitors to completely ablate spontaneous and OXT-induced contractions in myometrial strips [50] indicates that MYLK is the essential enzyme activity for force production. This would challenge the idea that protein kinases other than MYLK are involved in the regulation of myosin phosphorylation and myometrial contractility. However, our data in pregnant human myometrium clearly show that inhibition of ROCK has a marked effect on contractility (Figure 1) , and therefore we propose that, although the Ca 2 + -calmodulin/MYLK pathway is essential, ROCK-dependent Ca 2 + -sensitization supplements this pathway during phasic contractions.
Conclusions
The transition from uterine quiescence during pregnancy to the initiation of labour at term is likely to be mediated by changes in the expression, substrate availability, kinetics, activation (or inhibition) of the kinase network and associated regulatory proteins involved in the MYL↔pMYL equilibrium. In some cases, pre-term labour may be due to premature alterations in one or more of these pathways. More research needs to be conducted in human myometrial tissue to identify the signals that precipitate the increased contractility characteristic of labour.
